Pulmonary Hypertension Clinic, Section of Pulmonary, Sleep and Critical Care Medicine, Department of Medicine, West Virginia University School of Medicine, Morgantown, West Virginia 26505.
Director of Pulmonary Hypertension Program, Section of Pulmonary, Sleep and Critical Care Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York 10016, USA.
Curr Opin Pulm Med. 2023 Sep 1;29(5):329-339. doi: 10.1097/MCP.0000000000000993. Epub 2023 Jul 11.
Hospitalization in pulmonary arterial hypertension (PAH) patients is an important clinical worsening event significantly associated with subsequent mortality. Furthermore, irrespective of the cause of hospitalization, the overall outcome is closely related to the severity of the right ventricular (RV) dysfunction. Therefore, understanding the pathophysiology of pulmonary hypertension and RV failure is paramount in successfully managing PAH patients requiring hospitalization. This review highlights diagnostic and therapeutic approaches in various clinical scenarios that might be encountered during hospitalization of the World Health Organization group I PAH patient.
This article covers recent literature describing risk factors, predictors of outcome and state-of the art management approach to a hospitalized PAH patients with a special focus on management of RV failure and common complications in PAH requiring hospitalization.
The review highlights the importance of multidisciplinary approach to a hospitalized PAH patient and highlight important implications in clinical practice and knowledge gaps for potential future research.
肺动脉高压(PAH)患者住院是一个重要的临床恶化事件,与随后的死亡率密切相关。此外,无论住院的原因是什么,整体预后都与右心室(RV)功能障碍的严重程度密切相关。因此,了解肺动脉高压和 RV 衰竭的病理生理学对于成功管理需要住院的 PAH 患者至关重要。本篇综述重点介绍了在世界卫生组织 I 组 PAH 患者住院期间可能遇到的各种临床情况下的诊断和治疗方法。
本文涵盖了最近的文献,描述了风险因素、预后预测因素以及对住院 PAH 患者的最新管理方法,特别关注 RV 衰竭的管理和 PAH 住院常见并发症。
综述强调了对住院 PAH 患者进行多学科治疗的重要性,并强调了对临床实践的重要影响以及未来潜在研究的知识空白。